Valeo Pharma Stock Shares Owned By Institutions
| VPHIF Stock | USD 0.05 0.00 0.00% |
Valeo Pharma fundamentals help investors to digest information that contributes to Valeo Pharma's financial success or failures. It also enables traders to predict the movement of Valeo Pink Sheet. The fundamental analysis module provides a way to measure Valeo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valeo Pharma pink sheet.
Valeo |
Valeo Pharma Company Shares Owned By Institutions Analysis
Valeo Pharma's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of Valeo Pharma are shares owned by institutions. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The shares owned by institutions for all United States stocks is 100.0% higher than that of the company.
Valeo Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valeo Pharma's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Valeo Pharma could also be used in its relative valuation, which is a method of valuing Valeo Pharma by comparing valuation metrics of similar companies.Valeo Pharma is currently under evaluation in shares owned by institutions category among its peers.
Valeo Fundamentals
| Return On Equity | -16.0 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (0.93) % | |||
| Operating Margin | (0.61) % | |||
| Current Valuation | 57.28 M | |||
| Shares Outstanding | 82.19 M | |||
| Shares Owned By Insiders | 47.72 % | |||
| Price To Book | 66.75 X | |||
| Price To Sales | 2.14 X | |||
| Revenue | 27.75 M | |||
| Gross Profit | 8.52 M | |||
| EBITDA | (19.04 M) | |||
| Net Income | (25.75 M) | |||
| Cash And Equivalents | 27.72 M | |||
| Cash Per Share | 0.34 X | |||
| Total Debt | 59.53 M | |||
| Current Ratio | 2.88 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (28.5 M) | |||
| Earnings Per Share | (0.21) X | |||
| Number Of Employees | 115 | |||
| Beta | 2.47 | |||
| Market Capitalization | 35.68 M | |||
| Total Asset | 58.27 M | |||
| Net Asset | 58.27 M |
About Valeo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valeo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valeo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valeo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Valeo Pink Sheet
Valeo Pharma financial ratios help investors to determine whether Valeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valeo with respect to the benefits of owning Valeo Pharma security.